| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.082 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.069 | 0.3 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.047 | 0.4 |